Positive Phase II pain data with co-crystal of celecoxib and tramadol
This article was originally published in Scrip
Executive Summary
Esteve, a Spanish pharmaceutical company focused on developing novel pain therapies, has reported positive top-line results from a recently completed Phase II trial of its "co-crystal' acute pain product E-58425, a combination of celecoxib and tramadol.